NEW YORK (RLPC) - Valeant Pharmaceuticals International is offering to pay lenders a higher interest rate in order to obtain an amendment to its debt agreement that would loosen one of its covenants, according to sources.
Reuters: Business News, Reuters: Business
Tue, 08/09/2016 - 7:01pm
NEW YORK (RLPC) - Valeant Pharmaceuticals International is offering to pay lenders a higher interest rate in order to obtain an amendment to its debt agreement that would loosen one of its covenants, according to sources.